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Preventing and treating surgical 
site infection in patients with 
spinal metastatic disease
The surgical removal of metastatic (secondary) tumours from the spine is considered palliative treatment to relieve symptoms 
of pain, and impaired physical and neurological 
function associated with compression of the spinal 
cord (metastatic spinal cord compression [MSCC]; 
Quan et al, 2011). 
Healing of the surgical wound in these patients is 
difficult as they are often malnourished, catabolic, 
and immunosuppressed due to the malignant 
process. A number of risk factors for poor wound 
healing have previously been identified (McPhee 
et al, 1998; Olsen et al, 2003; Omeis et al, 2011). 
Therefore, it is not surprising that surgical site 
infection (SSI) occurs more frequently in spinal 
tumour patients, with reported rates being as high 
as 20%, as opposed to 1–5% in non-instrumented 
spinal fusion (McPhee et al, 1998). 
Highlighting interventions that may be effective 
in treating or preventing SSI will, therefore, improve 
practice and enhance quality of life for these patients, 
and will provide a focus for future research.
The aim of this article is to provide an overview of 
the published literature where interventions aimed 
at preventing or treating SSI in patients undergoing 
surgery to relieve MSCC have been reported.
METHODS
A systematic review of the literature based on search 
strategies recommended by the Cochrane back and 
wounds review groups was undertaken using the 
Cochrane Library, MEDLINE, EMBASE, CINAHL, 
and Web of Knowledge databases.
Any publications between 1900 and 2012 
(randomised controlled trials [RCTs] and non-RCTs, 
including case studies and evaluative studies) were 
eligible for inclusion if they included patients (of 
any sex, age or background) undergoing surgical 
treatment for spinal metastatic tumours, with any 
type of primary tumour. Any type of intervention 
aimed at preventing or treating SSI was deemed 
suitable for inclusion. Studies were assessed for 
outcomes relating to the presence/rate of SSI.
Two of the authors of this article (Ross Atkinson 
and Karen Ousey) reviewed the title and abstract of 
all results initially retrieved. Those deemed suitable 
for initial inclusion were reviewed in full. Articles that 
satisfied the inclusion criteria were then selected for 
analysis in this review.
RESULTS
The original search yielded 199 records. After 
removing duplicates and initial screening, 
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Surgery to remove secondary spinal tumours is oftennecessary to relieve symptoms
associatedwithmetastaticspinalcordcompression(MSCC).However,suchindividuals
areathighriskofsurgicalsiteinfection(SSI).Thisarticleaimstosummarisepublished
literaturereportinginterventionsusedtopreventortreatSSIinpeoplewithMSCC.A
systematic reviewof the literaturewasundertakenwith randomisedcontrolled trials
(RCTs)andnon-RCTsofanyinterventiontopreventortreatSSIeligibleforinclusionifa
MSCCpatientgroupwasreported.Sevenreportswereincluded,ofwhichonlyonewas
anRCT.Preventativeinterventionsincludedintraoperativewoundirrigationwithdilute
povidone-iodinesolution,postoperativeprostaglandinE1administration,useofaspecific
intraoperative antibiotic regimen, and soft-tissue reconstruction strategies following
surgery.Methodsto treatSSI involvedtheuseofsoft-tissuereconstructivestrategies.
SeveralmethodstopreventandtreatSSIinMSCCpatientsarehighlighted.However,
furtherhigh-levelresearchisneededtodeterminetheefficacyofsuchinterventions.
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37 publications were considered eligible and were 
reviewed in full. Thirty were excluded and seven 
fulfilled the inclusion criteria:
One was a prospective, single-blinded RCT 
(Cheng et al, 2005).
One was a retrospective and prospective study 
(Demura et al, 2009).
Five were retrospective studies (Disa et al, 2001; 
Vitaz et al, 2004; Mastronardi and Tatta, 2004; 
Chang et al, 2007; Garvey et al, 2010).
Preventative methods
A number of methods aimed at preventing SSI were 
identified. These included intraoperative irrigation 
of the wound with dilute povidone-iodine solution 
(Cheng et al, 2005), twice-daily postoperative 
prostaglandin E1 (PGE1) administration for 
7 days (Demura et al, 2009), the use of a specific, 
intraoperative antibiotic regimen (Mastronardi 
and Tatta, 2004), and soft-tissue reconstruction 
strategies following surgery for spinal metastases 
(Chang et al, 2007; Garvey et al, 2010).
None of the seven patients who contracted SSI 
in the RCT investigating povidone-iodine irrigation 
were spinal tumour patients (Cheng et al, 2005). 
Therefore, no further data from that study are 
reported in this review.
Postoperative PGE1 administration appeared to 
reduce SSI rate only in patients who had undergone 
pre-operative irradiation (SSI rate of 1/22 [5%] 
procedures with PGE1 vs 7/22 [32%] in the 
retrospective phase; Demura et al, 2009).
The specific intraoperative antibiotic regimen 
employed by Mastronardi and Tatta (2004) was safe 
and efficacious, but a significantly higher rate of SSI 
was observed in the tumour group (9.1% vs 0.9% in 
the entire cohort).
The rate of SSI was not reduced by the use of 
immediate soft-tissue reconstruction when the 
studies by Garvey et al (2010) and Chang et al 
(2007) are compared (8/52 cases vs 4/92 cases; 15% 
vs 4%, respectively).
Methods of treating SSI
Both publications describing methods to treat 
SSI and poor wound healing in MSCC patients 
involved the use of soft-tissue reconstructive 
strategies (Disa et al, 2001; Vitaz et al, 2004). 
These surgical techniques involved the use 
of muscle turnover and paraspinous advancement 
flaps. 
Out of the six patients included in their study, 
Disa et al (2001) reported two patients with 
infected open wounds who were treated with 
trapezius muscle turnover flaps. All muscle 
flaps survived, and primary wound healing was 
achieved.
Vitaz et al (2004) included 18 tumour patients 
in their study, 14 of which were treated effectively 
using muscle flaps because of infection, and four 
for dehiscence without infection.
Definition of SSI
Only one report (Mastronardi and Tatta, 2004) 
provided a definition of SSI that was based on 
recognised classification criteria (Horan et al, 
1992). Five studies did not include adequate 
information regarding the way SSI was defined 
or diagnosed (Disa et al, 2001; Vitaz et al, 2004; 
Chang et al, 2007; Demura et al, 2009; Garvey et al, 
2010).
Micro-organisms reported
Staphylococci were the most frequently reported 
bacteria. These were: coagulase-negative 
Staphylococcus (Mastronardi and Tatta, 2004; 
Demura et al, 2009), S aureus (Vitaz et al, 2004; 
Demura et al, 2009), Meticillin-resistance S aureus 
(MRSA; Demura et al, 2009), and S epidermidis 
(Mastronardi and Tatta, 2004; Vitaz et al, 2004).
Other organisms included Pseudomonas 
(Mastronardi and Tatta, 2004; Demura et al, 2009), 
Enterococcus faecalis (Vitaz et al, 2004; Demura 
et al, 2009), Escherichia coli  (Vitaz et al, 2004; 
Demura et al, 2009), Klebsiella (Mastronardi 
and Tatta, 2004), Candida albicans (Demura 
et al, 2009), Proprionibacterium acnes (Vitaz et al, 
2004), and Serratia (Vitaz et al, 2004).
Despite reporting on people with SSI, several 
studies failed to report any details on the types of 
micro-organism that may have been present (Disa 
et al, 2001; Chang et al, 2007; Garvey et al, 2010).
DISCUSSION
This systematic review highlights a number of 
published reports of interventions that may be 
useful in either preventing or treating SSI in a very 
specific high-risk group of patients. Unfortunately, 
“A number of 
methods aimed at 
preventing  surgical 
site infection were 
identified.”
WUK_9-2_74-8.indd   75 13/06/2013   10:58
 WoundsUK|Vol9|No2|20!3
REVIEW
76
the quality of these studies varied, with no high-
level evidence available to decisively conclude 
whether any of the interventions described are 
effective. Nevertheless, it should be recognised 
that dissemination of clinical experience and 
the use of somewhat unconventional methods 
can often lead to further research where there is 
adequate theory to support such interventions.
Prevention of infection in the first instance is 
of utmost importance to the patient, clinician, 
and society in general for a number of reasons. 
SSI can be a devastating consequence of any 
surgical procedure. In operations involving the 
implantation of prostheses (as in the majority 
of spinal tumour cases), wound infection could 
result in removal of instrumentation and severely 
compromises surgical outcome. Furthermore, 
longer in-patient stay, severe pain, a number of 
diagnostic tests, treatments (including antibiotic 
therapy), and often further surgery, all adversely 
affect an individual’s quality of life. 
The recent rise of resistant strains of bacteria 
due to persistent over-use of antibiotics means 
that stewardship of these valuable treatments is 
paramount now more than ever. All of these factors 
exacerbate the already high costs associated with 
complex surgical procedures and impose a huge 
financial burden on budgets and compromises the 
capacity of health systems to provide appropriate 
standards of care.
It is interesting that interventions aimed at three 
important areas of practice have been identified 
in the literature pertaining to MSCC patients 
undergoing surgery. The use of pharmacological 
interventions, antiseptics, and variations in 
surgical techniques highlights that a multi-faceted 
approach is needed to reduce the likelihood of 
infection and optimise outcomes. This is certainly 
advocated in the UK by the SSI prevention and 
treatment guidelines set out by the NICE, which 
brings together evidence on a host of interventions 
that can be employed at the pre-, intra-, and 
postoperative stages (NICE, 2008). Care bundles 
have been shown to be effective in reducing the 
incidence of SSI in some areas (Acklin et al, 2011) 
and have been incorporated into advice of the 
National Patient Safety Agency (NPSA) since the 
introduction of the World Health Organization 
(WHO) surgical safety checklist (National Patient 
Safety Agency [NPSA], 2009).
Appropriate antibiotic prophylaxis in spinal 
surgery is an important step in the pre-operative 
phase. Despite showing a relatively low SSI rate 
with the use of their specific antibiotic regimen, 
Mastronardi and Tatta (2004) also highlight 
that infection may be more common in tumour 
patients. This is in agreement with previous studies 
which have shown that surgery for spinal tumours 
is a risk factor for SSI (Olsen et al, 2003).  
The North American Spine Society (NASS) 
states that existing literature is sufficient to 
recommend the use of prophylactic antibiotics 
for spinal surgery (NASS, 2007). Similarly, NICE 
recommends that antibiotic prophylaxis be 
administered in all cases involving placement of 
an implant (NICE, 2008). It has been suggested 
that future research should utilise existing 
datasets to investigate the efficacy of various 
antibiotic protocols, identify populations at high 
risk of infection, and evaluate the utility of broad 
spectrum antibiotic coverage in reducing SSI rates 
in high-risk populations treated with instrumented 
fusion (NASS, 2007). Patients with spinal 
metastases constitute one such high-risk group.
Use of pharmacological interventions as 
prophylactic measures – other than antibiotic 
prophylaxis alone – is also an area which may 
deserve further attention. PGE1 is a potent 
vasodilator and acts to increase peripheral blood 
flow, which has been cited as one possible way 
it may act to reduce SSI in people with diabetes 
(Demura et al, 2009). 
Previously, Shiga et al, 2002 conducted a 
small retrospective study of people undergoing 
laryngectomy procedures and found that a lower 
complication rate was associated with those 
administered PGE1 after surgery. Despite this, 
a higher rate of infection has been observed in 
neonates undergoing cardiac surgery who were 
treated pre-operatively with PGE1 (Fleming 
et al, 1984). Erez et al also reported pre-operative 
administration of PGE1 in children undergoing 
cardiac surgery, but no explanation was given as to 
the reason for its usage, or the effect on preventing 
or treating infection (Erez et al, 2000). Given that 
the majority of complex spinal procedures are 
“The recent rise of 
resistant strains 
of bacteria due to 
persistent over-
use of antibiotics 
means that 
stewardship of 
these valuable 
treatments is 
paramount now 
more than ever.”
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undertaken in non-infants, administration of PGE1 
in the postoperative phase may be feasible and 
worthy of further investigation.
The use of antiseptics is an area which may 
potentially benefit from further research. Skin 
preparation using chlorhexidine in alcohol has 
been shown to be superior to povidone-iodine 
(Darouiche et al, 2010), and has subsequently 
been adopted as standard by a number of surgical 
areas. However, current NICE guidance advises 
against the use of wound irrigation (including 
with antiseptics) to prevent SSI. This is despite 
evidence suggesting that irrigation with povidone-
iodine solutions prior to closure may be effective in 
reducing SSI rate (Chundamala and Wright, 2007; 
Fournel et al, 2010). Further work to assess the 
utility of antiseptics as wound irrigants to prevent 
SSI may be warranted, but the benefits and risks of 
their use at certain concentrations in orthopaedic 
surgery should be carefully considered (Kaysinger 
et al, 1995).
A number of studies described less conventional 
surgical strategies to aid wound closure. 
These involved the use of muscle flaps, both 
prophylactically to prevent SSI, and to treat poorly 
healing or infected wounds. These techniques 
aim to rebuild anatomy and preserve external 
appearance, restore function, and achieve optimal 
quality of life for the patient (Dolan et al, 2012).  It 
is understandable that such methods may be less 
favourable aesthetically. However, in cases where 
life expectancy is limited (for example, those 
treated palliatively for spinal metastases), patients 
and clinicians must assess the advantages and 
disadvantages of such techniques that may offer 
superior surgical outcomes over desired aesthetic 
appearance, bearing in mind that a poor aesthetic 
outcome may also impact negatively on quality of 
life (Dolan et al, 2012). While evidence exists to 
suggest that the rate of major complications (i.e. 
those requiring further surgical treatment) may 
be reduced by employing alternative soft-tissue 
reconstruction strategies (Garvey et al, 2010), 
further research may be needed to ascertain 
whether these methods are also associated with 
lower rates of SSI.
Few studies reporting SSI in this review 
described the way this outcome was defined. 
While some reported the types of micro-organism 
cultured, insufficient detail regarding the criteria 
for determining SSI was evident in most. This 
leaves the reader to assume that microbiological 
results were perhaps the only criterion for the 
diagnosis of infection. 
Since positive cultures have the potential to 
result from contaminated samples obtained from 
the wound, or may simply be an indication of 
bacterial colonisation, it is imprudent to diagnose 
SSI on microbiology alone. Therefore, it is 
important that studies reporting SSI take great care 
in defining how this was classified and diagnosed, 
with the recommendation that clinical signs of 
infection are considered in conjunction with results 
of microbiological examination where appropriate 
(Bowler et al, 2001; Patel, 2007). 
In particular, authors should use and cite 
recognised SSI classification systems such as 
the Centers for Disease Control and Prevention 
definition (Horan et al, 1992) where possible, and 
be aware of alternative ways to classify SSI which 
generate interval data to determine the severity 
of SSI (Williams et al, 2011). Examples of such 
systems include the ASEPSIS (Wilson et al, 1986) 
and Southampton (Bailey et al, 1992) scores. 
Investigators should also ensure that the personnel 
diagnosing SSI are appropriately qualified to do 
so and that surveillance is undertaken rigorously. 
Such standardisation measures will ensure accurate 
reporting of SSI rates and enable valid comparison 
between centres and studies (Tanner et al, 2012).
CONCLUSION
This review highlights the limited number of 
reports that have investigated methods to prevent 
and treat SSI in patients undergoing surgery for 
spinal metastatic tumours. Appropriate antibiotic 
prophylaxis is an extremely important factor in 
preventing against SSI in these procedures that 
involve the implantation of instrumentation. 
Other pharmacological interventions such as the 
use of PGE1 in the Postoperative phase may also 
contribute towards reducing the rate of wound 
infection and may deserve further investigation. 
Furthermore, unconventional surgical approaches 
to wound closure may provide good outcomes in 
patients where wound healing is severely impaired, 
with or without infection, or where tissue coverage 
is insufficient. 
“It is important 
that studies 
reporting surgical 
site infection 
take great care in 
defining how this 
was classified and 
diagnosed.”
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While there is currently no published evidence 
determining the efficacy of the use of antiseptics 
specifically in patients with spinal metastases, 
their successful employment in other areas of 
surgery indicate that they too play an important 
role in reducing the risk of infection. Current 
NICE guidance encourages the adoption of a 
rigorous, multifaceted approach to the prevention 
of SSI, which can be promoted through an SSI 
care bundle approach. Wuk
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